Atossa Therapeutics (ATOS) Shares Outstanding (Diluted) (2022 - 2026)
Atossa Therapeutics (ATOS) posted Shares Outstanding (Diluted) of 8.91 million for Q2 2026, up 3.4% from 8.61 million a year earlier and up 3.3% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025, Atossa Therapeutics' Shares Outstanding (Diluted) came in at 8.61 million, up 2.6% from FY2024.
- Annual Shares Outstanding (Diluted) shows a three-year compound annual growth rate of 0.7% (FY2022 to FY2025).
- In prior years, Atossa Therapeutics' Shares Outstanding (Diluted) was 8.39 million in FY2024 (-0.2%), 8.41 million in FY2023 (-0.4%) and 8.44 million in FY2022.
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2022.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased in each of the last six quarters, with growth averaging 1.8% over the last eight quarters.
- The strongest year-over-year quarter for Shares Outstanding (Diluted) in the past five years was Q2 2026, with growth of 3.4%; the weakest was Q1 2024, with a decline of 1.0%.
- According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 8.62 million (Q1 2026), 8.61 million (Q4 2025) and 8.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Atossa Therapeutics | 22.65 Mn | 22.65 Mn | - | 8.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.91 Mn |
| Mar 31, 2026 | 8.62 Mn |
| Dec 31, 2025 | 8.61 Mn |
| Sep 30, 2025 | 8.61 Mn |
| Jun 30, 2025 | 8.61 Mn |
| Mar 31, 2025 | 8.61 Mn |
| Dec 31, 2024 | 8.39 Mn |
| Sep 30, 2024 | 8.39 Mn |
| Jun 30, 2024 | 8.38 Mn |
| Mar 31, 2024 | 8.36 Mn |
| Dec 31, 2023 | 8.41 Mn |
| Sep 30, 2023 | 8.39 Mn |
| Jun 30, 2023 | 8.44 Mn |
| Mar 31, 2023 | 8.44 Mn |
| Dec 31, 2022 | 8.44 Mn |
API Access
Atossa Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();